Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: Risk factors and influence on treatment outcome

European Urology

Volumn 58, Issue 6, 2010, Pages 919-926

  Kuo, Hann Chorng ^a   Liao, Chun Hou ^b   Chung, Shiu Dong ^c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adverse events; Botulinum toxin; Detrusor overactivity; Overactive bladder

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OVERACTIVE BLADDER; PERCEPTION; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSTATE; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE RETENTION; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS, TYPE A; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS; YOUNG ADULT;

EID: 78049454598     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.09.007     Document Type: Article

References (29)

1. H.C. Kuo Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents Urology 63 2004 868 872
2. T.M. Kessler, H. Danuser, M. Schumacher, V.E. Studer, and F.C. Burkhard Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24 2005 231 236
3. M. Werner, D.M. Schmid, and B. Schussler Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study Am J Obstet Gynecol 192 2005 1735 1740
4. H.C. Kuo Clinical effects of suburothelial injection of botulinum A toxin in patients with non-neurogenic detrusor overactivity refractory to anticholinergics Urology 66 2005 94 98
5. H. Schulte-Baukloh, C. Weiss, T. Stolze, B. Sturzebecher, and H.H. Knispel Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: Urodynamic outcome and patient satisfaction Urology 66 2005 82 87 (Pubitemid 41002192)
6. G.N. Rajkumar, D.R. Small, A.W. Mustafa, and G. Conn A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity BJU Int 96 2005 848 852
7. D.M. Schmid, P. Sauermann, and M. Werner Experience with 100 cases treated with botulinum-a toxin injections in the detrusor muscle for idiopathic overactive bladder J Urol 176 2006 177 185
8. H.C. Kuo Will suburothelial injection of a small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity? Urology 68 2006 993 997
9. R. Popat, A. Apostolidis, V. Kalsi, G. Gonzales, C.J. Fowler, and P. Dasgupta A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin J Urol 174 2005 984 989
10. A. Sahai, M.S. Khan, and P. Dasgupta Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial J Urol 177 2007 2231 2236
11. L. Brubaker, H.E. Richter, and A. Visco Refractory idiopathic urge urinary incontinence and botulinum A injection J Urol 180 2008 217 222
12. H.C. Kuo Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin A for idiopathic detrusor overactivity J Urol 178 2007 1359 1363
13. S. Jeffery, M. Fynes, F. Lee, K. Wang, L. Williams, and R. Morley Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity BJU Int 100 2007 1302 1306
14. Dmochowski R, Chapple C, Nitti V, et al. Botulinum toxin type A (onabotulinumtoxinA) demonstrates dose-dependent efficacy and safety in idiopathic overactive bladder: a double-blind, placebo-controlled, randomized trial. Abstract presented at: American Urological Association Annual Meeting; April 25-30, 2009; Chicago, IL, USA.
15. S. Khan, J. Panicker, and A. Roosen Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks Eur Urol 57 2010 891 896
16. W.M. White, R.B. Pickens, R. Doggweiller, and F.A. Klein Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population J Urol 180 2008 2522 2526
17. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167 178 (Pubitemid 34195211)
18. K.S. Coyne, L.S. Matza, Z. Kopp, and P. Abrams The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder Eur Urol 49 2006 1079 1086
19. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
20. M. Ghei, B.H. Maraj, and R. Miller Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial J Urol 174 2005 1873 1877
21. V. Kalsi, A. Apostolidis, and G. Gonzales Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity Eur Urol 54 2008 181 187
22. B.L. Cohen, P. Barboglio, D. Rodriguez, and A.E. Gousse Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units Neurourol Urodyn 28 2009 205 208
23. J.T. Anger, A. Weinberg, and M.J. Suttorp Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature J Urol 183 2010 2258 2264
24. S. Khan, T.M. Kessler, and A. Apostolidis What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection J Urol 181 2009 1773 1778
25. M.K. Flynn, C.L. Amundsen, M. Perevich, F. Liu, and G.D. Webster Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder J Urol 181 2009 2608 2615
26. A. Sahai, P. Sangster, V. Kalsi, M.S. Khan, C.J. Fowler, and P. Dasgupta Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable? BJU Int 103 2009 630 634
27. A. Apostolidis, P. Dasgupta, and P. Denys Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report Eur Urol 55 2009 100 120
28. A. Giannantoni, E. Mearini, M. Del Zingaro, and M. Porena Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results Eur Urol 55 2009 705 711
29. H.C. Kuo Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection Urology 72 2008 1056 1060